IBDEI0XA ; ; 06-AUG-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,16182,1,5,0)
 ;;=5^Hypothyroidism NOS
 ;;^UTILITY(U,$J,358.3,16182,2)
 ;;=^123752
 ;;^UTILITY(U,$J,358.3,16183,0)
 ;;=790.21^^81^955^45
 ;;^UTILITY(U,$J,358.3,16183,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16183,1,4,0)
 ;;=4^790.21
 ;;^UTILITY(U,$J,358.3,16183,1,5,0)
 ;;=5^Impaired Fasting Glucose
 ;;^UTILITY(U,$J,358.3,16183,2)
 ;;=^329895
 ;;^UTILITY(U,$J,358.3,16184,0)
 ;;=790.5^^81^955^51
 ;;^UTILITY(U,$J,358.3,16184,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16184,1,4,0)
 ;;=4^790.5
 ;;^UTILITY(U,$J,358.3,16184,1,5,0)
 ;;=5^Liver Enzymes,Elevated
 ;;^UTILITY(U,$J,358.3,16184,2)
 ;;=^273402
 ;;^UTILITY(U,$J,358.3,16185,0)
 ;;=724.2^^81^955^52
 ;;^UTILITY(U,$J,358.3,16185,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16185,1,4,0)
 ;;=4^724.2
 ;;^UTILITY(U,$J,358.3,16185,1,5,0)
 ;;=5^Low Back Pain,Chronic
 ;;^UTILITY(U,$J,358.3,16185,2)
 ;;=^71885
 ;;^UTILITY(U,$J,358.3,16186,0)
 ;;=412.^^81^955^56
 ;;^UTILITY(U,$J,358.3,16186,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16186,1,4,0)
 ;;=4^412.
 ;;^UTILITY(U,$J,358.3,16186,1,5,0)
 ;;=5^Myocardial Infarction-Old
 ;;^UTILITY(U,$J,358.3,16186,2)
 ;;=^259884
 ;;^UTILITY(U,$J,358.3,16187,0)
 ;;=250.60^^81^955^58
 ;;^UTILITY(U,$J,358.3,16187,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16187,1,4,0)
 ;;=4^250.60
 ;;^UTILITY(U,$J,358.3,16187,1,5,0)
 ;;=5^Neuropathy,Diabetic
 ;;^UTILITY(U,$J,358.3,16187,2)
 ;;=^331803^357.2
 ;;^UTILITY(U,$J,358.3,16188,0)
 ;;=V15.81^^81^955^59
 ;;^UTILITY(U,$J,358.3,16188,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16188,1,4,0)
 ;;=4^V15.81
 ;;^UTILITY(U,$J,358.3,16188,1,5,0)
 ;;=5^Noncompliance
 ;;^UTILITY(U,$J,358.3,16188,2)
 ;;=^295290
 ;;^UTILITY(U,$J,358.3,16189,0)
 ;;=278.00^^81^955^60
 ;;^UTILITY(U,$J,358.3,16189,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16189,1,4,0)
 ;;=4^278.00
 ;;^UTILITY(U,$J,358.3,16189,1,5,0)
 ;;=5^Obesity
 ;;^UTILITY(U,$J,358.3,16189,2)
 ;;=^84823
 ;;^UTILITY(U,$J,358.3,16190,0)
 ;;=278.02^^81^955^62
 ;;^UTILITY(U,$J,358.3,16190,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16190,1,4,0)
 ;;=4^278.02
 ;;^UTILITY(U,$J,358.3,16190,1,5,0)
 ;;=5^Overweight
 ;;^UTILITY(U,$J,358.3,16190,2)
 ;;=^332745
 ;;^UTILITY(U,$J,358.3,16191,0)
 ;;=715.90^^81^955^61
 ;;^UTILITY(U,$J,358.3,16191,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16191,1,4,0)
 ;;=4^715.90
 ;;^UTILITY(U,$J,358.3,16191,1,5,0)
 ;;=5^Osteoarthritis,Unspec
 ;;^UTILITY(U,$J,358.3,16191,2)
 ;;=^272161
 ;;^UTILITY(U,$J,358.3,16192,0)
 ;;=728.71^^81^955^65
 ;;^UTILITY(U,$J,358.3,16192,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16192,1,4,0)
 ;;=4^728.71
 ;;^UTILITY(U,$J,358.3,16192,1,5,0)
 ;;=5^Plantar Fascitis
 ;;^UTILITY(U,$J,358.3,16192,2)
 ;;=^272598
 ;;^UTILITY(U,$J,358.3,16193,0)
 ;;=486.^^81^955^66
 ;;^UTILITY(U,$J,358.3,16193,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16193,1,4,0)
 ;;=4^486.
 ;;^UTILITY(U,$J,358.3,16193,1,5,0)
 ;;=5^Pneumonia
 ;;^UTILITY(U,$J,358.3,16193,2)
 ;;=^95632
 ;;^UTILITY(U,$J,358.3,16194,0)
 ;;=185.^^81^955^79
 ;;^UTILITY(U,$J,358.3,16194,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16194,1,4,0)
 ;;=4^185.
 ;;^UTILITY(U,$J,358.3,16194,1,5,0)
 ;;=5^Prostate Cancer
 ;;^UTILITY(U,$J,358.3,16194,2)
 ;;=^99481
 ;;^UTILITY(U,$J,358.3,16195,0)
 ;;=791.0^^81^955^80
 ;;^UTILITY(U,$J,358.3,16195,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16195,1,4,0)
 ;;=4^791.0
 ;;^UTILITY(U,$J,358.3,16195,1,5,0)
 ;;=5^Proteinuria
 ;;^UTILITY(U,$J,358.3,16195,2)
 ;;=^99873
 ;;^UTILITY(U,$J,358.3,16196,0)
 ;;=790.93^^81^955^63
 ;;^UTILITY(U,$J,358.3,16196,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16196,1,4,0)
 ;;=4^790.93
 ;;
 ;;$END ROU IBDEI0XA
